PL365778A1 - Nowe związki tiazolo (4,5) pirymidynowe - Google Patents

Nowe związki tiazolo (4,5) pirymidynowe

Info

Publication number: PL365778A1
Authority: PL; Poland
Prior art keywords: pyrimidine compounds; solvate; chem; therapy; processes
Prior art date: 1999-10-01

Application number

PL00365778A

Other languages

English (en)

Other versions

PL203572B1 (pl

Inventor

Paul Andrew Willis

Roger Victor Bonnert

Simon Fraser Hunt

Iain Alistair Stewart Walters

Original Assignee

Astrazeneca Uk Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-01

Filing date

2000-09-26

Publication date

2005-01-10

2000-09-26 Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited

2005-01-10 Publication of PL365778A1 publication Critical patent/PL365778A1/pl

2009-10-30 Publication of PL203572B1 publication Critical patent/PL203572B1/pl

Links

YWBULOYFCXZCGF-UHFFFAOYSA-N [1,3]thiazolo[4,5-d]pyrimidine Chemical class C1=NC=C2SC=NC2=N1 YWBULOYFCXZCGF-UHFFFAOYSA-N 0.000 title 1
239000000543 intermediate Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
238000002560 therapeutic procedure Methods 0.000 abstract 2
-1 thiazolopyrimidine compounds Chemical class 0.000 abstract 2
102000019034 Chemokines Human genes 0.000 abstract 1
108010012236 Chemokines Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL365778A 1999-10-01 2000-09-26 Zwi azek tiazolo[4,5-d]pirymidynowy, sposób jego wytwarzania, zwi azki po srednie, srodek farmaceutyczny oraz zastosowanie tego zwi azku PL203572B1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9903544-6		1999-10-01
SE9903544A SE9903544D0 (sv)	1999-10-01	1999-10-01	Novel compounds
PCT/GB2000/003692 WO2001025242A1 (en)	1999-10-01	2000-09-26	Novel thiazolo(4,5-d)pyrimidine compounds

Publications (2)

Publication Number	Publication Date
PL365778A1 true PL365778A1 (pl)	2005-01-10
PL203572B1 PL203572B1 (pl)	2009-10-30

Family

ID=

Also Published As

Publication number	Publication date
IS2229B (is)	2007-04-15
NZ517880A (en)	2003-09-26
MXPA02003263A (es)	2002-09-30
DE60007768T2 (de)	2004-12-02
DE60037836T2 (de)	2009-01-15
AU7304900A (en)	2001-05-10
BR0014334A (pt)	2002-06-11
NO20021448L (no)	2002-05-22
AU777872B2 (en)	2004-11-04
JP4824889B2 (ja)	2011-11-30
ES2298451T3 (es)	2008-05-16
EP1222195B1 (en)	2004-01-14
TWI260324B (en)	2006-08-21
ATE257838T1 (de)	2004-01-15
WO2001025242A1 (en)	2001-04-12
DE60007768D1 (de)	2004-02-19
HK1052009A1 (zh)	2003-08-29
DK1222195T3 (da)	2004-04-19
UA73521C2 (en)	2005-08-15
ES2213043T3 (es)	2004-08-16
IL148910A (en)	2006-10-31
CN1402730A (zh)	2003-03-12
HUP0204246A2 (hu)	2003-04-28
JP2003511384A (ja)	2003-03-25
EE05037B1 (et)	2008-06-16
ZA200202380B (en)	2003-10-29
EP1348709B1 (en)	2008-01-16
EP1348709A3 (en)	2003-11-19
CZ20021113A3 (cs)	2002-06-12
US6790850B1 (en)	2004-09-14
IS6306A (is)	2002-03-18
DE60037836D1 (de)	2008-03-06
CA2385269A1 (en)	2001-04-12
PT1222195E (pt)	2004-05-31
CA2385269C (en)	2010-08-17
IL148910A0 (en)	2002-09-12
US20040224961A1 (en)	2004-11-11
EE200200174A (et)	2003-04-15
NO20021448D0 (no)	2002-03-22
HUP0204246A3 (en)	2006-01-30
SE9903544D0 (sv)	1999-10-01
CN1210279C (zh)	2005-07-13
EP1222195A1 (en)	2002-07-17
US8143261B2 (en)	2012-03-27
KR100765051B1 (ko)	2007-10-09
KR20020032635A (ko)	2002-05-03
NO327706B1 (no)	2009-09-14
US20090281123A1 (en)	2009-11-12
ATE384068T1 (de)	2008-02-15
EP1348709A2 (en)	2003-10-01

Publication	Publication Date	Title
IL148910A0 (en)	2002-09-12	Novel thiazolo (4,5-d) pyrimidine compounds
CA2272705A1 (en)	1998-06-04	Fused bicyclic pyrimidine derivatives
SE9702001D0 (sv)	1997-05-28	Novel compounds
CA2400217A1 (en)	2001-08-30	Pteridine compounds for the treatment of psoriasis
ATE248837T1 (de)	2003-09-15	Chinuclidin-acrylamide
AP2000001860A0 (en)	2000-09-30	Hypolipidemic benzothiazepine compounds.
CA2338600A1 (en)	2000-02-24	Novel thiazolopyrimidine compounds
IL158667A0 (en)	2004-05-12	Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections
GB9305295D0 (en)	1993-05-05	Therapeutic compounds
IL147149A0 (en)	2002-08-14	Novel diphenyl-piperidine derivate
GR3020050T3 (en)	1996-08-31	Leukotriene B4 antagonist
GB9310095D0 (en)	1993-06-30	Therapeutic compounds
GB0104050D0 (en)	2001-04-04	Chemical compounds
SE0101322D0 (sv)	2001-04-12	Novel compounds
IT1223395B (it)	1990-09-19	Composti ad attivita' cardiovascolare
EP0276805A3 (en)	1989-03-22	Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
MXPA99003849A (es)	2003-09-23	Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
WO1999019324A3 (en)	1999-07-01	Antipsychotic substituted piperidine derivatives